Gynecologic oncology research and practice

Gynecol Oncol Res Pract · ISSN (e) 2053-6844 · 6 papers in corpus
article 2019
doi:10.1186/s40661-019-0067-7 ·PMID:30723546

BACKGROUND: Endometrial stromal sarcoma (ESS) is a rare neoplasm accounting for only 0.2% of female genital tract tumors. The primary extra-uterine location of ESS is an extremely uncommon occurrence. CASE PRESENTATION: We present a case of…

2018
doi:10.1186/s40661-018-0065-1 ·PMID:30410774

BackgroundWidespread concerns have been raised regarding the safety of power morcellation of uterine specimens because of the potential to disseminate occult malignancy. We sought to assess the safety and feasibility of contained manual ute…

2017
doi:10.1186/s40661-017-0052-y ·PMID:29093822

Clear cell carcinoma and endometrioid adenocarcinoma are histologic subtypes of ovarian and uterine cancer that demonstrate unique clinical behavior but share common underlying genomic aberrations and oncogenic pathways. ARID1A mutations ar…

2015
doi:10.1186/s40661-015-0008-z ·PMID:27231561

Traditionally, epithelial ovarian, tubal, and peritoneal cancers have been viewed as separate entities with disparate origins, pathogenesis, clinical features, and outcomes. Additionally, previous classification systems for ovarian cancer h…

2015
doi:10.1186/s40661-015-0014-1 ·PMID:27231565

Recently accumulated evidence has strongly indicated that the fallopian tube is the site of origin for the majority of high-grade serous ovarian or peritoneal carcinomas. As a result, recommendations have been made to change surgical practi…

2015
doi:10.1186/s40661-015-0013-2 ·PMID:27231564

PurposeCompared to other subtypes of epithelial ovarian cancer, clear cell carcinoma of the ovary bears an ominous reputation for chemotherapy resistance, increased relapse rate, and diminished survival. Among patients with distinct histopa…